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ABSTRACT 
Background: RS3PE stands for remitting seronegative symmetrical synovitis with pitting edema thus described 
in some literature worldwide as a group of symptoms or a syndrome and first described by McCarty in 1985. 
RS3PE is also known as a rare form of rheumatology pathologic condition correlates with inflammatory 
arthritis. In past years, the diagnosis of RS3PE should raise the clinician suspicion of the more aggressive 
possibility of underlying malignancy. Rheumatology and malignancy can share some of its symptoms in various 
ways, especially in the musculoskeletal system as the main rheumatology focus. Methods: Literature review is 
the used method that focused on publication between January 2011 to 2020 to keep up with the current medical 
science, which is done using certain keywords. Discussion: There is a plethora of literature describing 
paraneoplastic syndrome and its relation with underlying malignancy, especially prostate and lung 
adenocarcinoma. RS3PE itself is closely related to VEGF either its idiopathic form or paraneoplastic form; thus, 
the clinical feature appears similar. In terms of malignancies, VEGF acts as a key role in its pathology as an 
important growth factor because of VEGF nature as a potent angiogenic molecule. In some malignancies, the 
VEGF level also appears to be higher than normal, thus suggesting an explanation of paraneoplastic syndrome’s 
nature. Conclusion: RS3PE has been strongly correlated with several malignancies mostly prostate cancer; thus 
should raise the awareness of clinician its signs and symptoms exist in a ce1rtain risky group even if the “pure” 
form of RS3PE exists. 
Keywords: malignancy, paraneoplastic syndrome, rheumatology, RS3PE 
 
ABSTRAK 
Latar Belakang: RS3PE merupakan singkatan dari remitting seronegative symmetrical synovitis with pitting 
edema sehingga dideskripsikan pada berbagai literatur di seluruh dunia sebagai kumpulan gejala atau 
sindroma yang pertama kali disebutkan oleh McCarty pada tahun 1985. RS3PE juga diketahui sebagai bentuk 
kondisi reumatologi patologis yang berkorelasi dengan artritis inflamatorik. Beberapa tahun terakhir, 
diagnosis dari RS3PE harus meningkatkan kecurigaan seorang praktisi kesehatan terhadap keganasan yang 
melatarbelakangi. Reumatologi dan keganasan juga memiliki beberapa kesamaan perihal gejala dalam bentuk 
yang berbeda-beda terlebih pada sistem muskuloskeletal sebagai fokus utama reumatologi. Metode: Tinjauan 
pustaka merupakan metode yang digunakan dan berfokus pada publikasi pada rentang waktu Januari 2011 
hingga Desember 2020 sehingga penulisan manuskrip ini masih berdasarkan pengetahuan medis yang 
terbarukan dan dilakukan menggunakan beberapa kata kunci. Pembahasan: Cukup banyak manuskrip yang 
telah diterbitkan untuk mendeskripsikan sindroma paraneoplastik dan korelasinya terhadap suatu keganasan. 
RS3PE, sebagai suatu sindroma paraneoplastik telah dilaporkan oleh berbagai praktisi kesehatan seluruh 
dunia mengenai korelasinya tehadap beberapa patologi keganasan terutama pada organ prostat, paru, dan 
kolorektal. RS3PE sendiri erat dikaitkan dengan VEGF baik bentuk idiopatiknya ataupun bentuk 
paraneoplastiknya. Perihal keganasan, VEGF memiliki peranan yang cukup vital dalam patologinya terkhusus 
pada faktor pertumbuhan oleh karena sifat dari VEGF sebagai molekul angiogenik potensial. Pada beberapa 
keganasan, nilai VEGF ditemukan lebih tinggi daripada populasi normal sehingga diduga, menjelaskan 
penyebab dari suatu kejadian sindroma paraneoplastic. Kesimpulan: RS3PE telah dikorelasikan dengan erat 
terhadap beberapa keganasan terutama kanker prostat dan kanker kolorektal dengan jumlah yang lebih sedikit 
sebagai etiologi dari RS3PE sebagai suatu sindroma paraneoplastik walaupun bentuk idiopatiknya ada. 
Kata Kunci: keganasan, reumatologi, RS3PE, sindroma paraneoplastik 
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RS3PE stands for remitting 
seronegative symmetrical synovitis with 
pitting edema thus described in some 
literature worldwide as a group of 
symptoms or a syndrome and first 
described by McCarty in 1985. Acute-
onset, tendency to affect the elderly 
especially male, respond rapidly to 
corticosteroid treatment even at the low 
dose, absence of bony erosions on the 
radiograph, and most importantly always 
appear to be a rheumatoid factor (RF) 
negative are some feature of this 
syndrome.[1-4] RS3PE is also known as a 
rare form of rheumatology pathologic 
condition correlates with inflammatory 
arthritis. Nowadays, current pathology 
including the pathogenesis and 
pathophysiology of the syndrome remains 
unclear and poorly understood.[5]  
The sign and symptoms of RS3PE are 
strongly associated with other pathologic 
condition such as polymyalgia rheumatic 
(PMR) and rheumatoid arthritis (RA) but 
also correlates with other rheumatological 
condition such as spondyloarthritides and 
associated condition, amyloid arthropathy, 
crystal-induced arthritis, mainly articular 
chondrocalcinosis, Sudeck’s atrophy, 
mixed connective tissue disease (MCTD) 
or Sharp’s syndrome, and sarcoidosis.[1,3,6] 
As it definition, the symptoms of RS3PE is 
the pitting edema on the limb (dorsum of 
the hand is more common than dorsum of 
the feet) and symmetrical polyarthritis as 
the hallmark of the syndrome. In past 
years, the diagnosis of RS3PE should raise 
the clinician suspicion to the more 
aggressive possibility of underlying 
malignancy as RS3PE can also appear in 
the form of paraneoplastic syndrome 
besides its “pure” form.[1,4-9] 
Rheumatology and malignancy can 
share some of its symptoms in various 
ways especially in the musculoskeletal 
system as the main rheumatology focus. In 
other words, malignancy can induce some 
of the rheumatic symptoms as its clinical 
manifestation although the symptoms 
appear to be a trivial one and distant from 
the main affected tissue or organ.[10-11] A 
clinician can consider someone having a 
paraneoplastic syndrome associated with 
rheumatic symptoms when its affected 
musculoskeletal symptoms appear 
simultaneously and no longer than one 
year. There are several rheumatic 
conditions considered as a paraneoplastic 
syndrome such as paraneoplastic arthritis 
(PA), palmar fasciitis, and polyarthritis 
syndrome (PEPAS), paraneoplastic 
vasculitis, hypertrophic osteoarthropathy 
(HOA) and also RS3PE.[10-12] Some of the 
more common diagnoses of the rheumatic 
conditions including dermatomyositis 
(DM), PMR, Sjogren’s syndrome, 
scleroderma, and vasculitides also appear 
to be related to some cases of malignancy 
even there is some diversity in some 
international studies regarding this 
information. The diagnosed malignancy is 
known to involve multi-system. Also, 
there is a massive variation between 
underlying malignancy and manifested 
pathology with adenocarcinoma as the 
most commonly diagnosed malignancy in 
rheumatologic patients.[11,13-16] 
The exact mechanism of the 
underlying relation between paraneoplastic 
rheumatic syndrome and underlying 
malignancy has been extensively 
hypothesized.[11] Cancer-induced auto-
immunity, several unique auto-antibodies 
in certain rheumatic condition, e.g., anti-
RNAP III in scleroderma and TIF1γ in 
DM, genetic alteration of autoantigen as 
the source of the inflammatory reaction, 
and also toxins produced by the underlying 
malignancy is several known theories to 
explain the distinction of manifested 
symptoms no exception in RS3PE. It’s 
believed, the symptoms of either 
paraneoplastic syndrome or some cases of 
rheumatic condition will subside if the 
underlying malignancy is treated well or 
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The literature review is the used 
method in this literature writing. The 
source of the literature consists of relevant 
journal and manuscript that published 
between 2011 and 2020 using some 
keywords such as “RS3PE,” 
“Paraneoplastic Syndrome,” 
“Rheumatological Condition,” and 
“Malignancy,”. The writer uses 
ScienceDirect, PubMed, Google Scholar 
dan ClinicalKey as the search engine in 
order to search related manuscripts. The 
used inclusion criteria are full-text 
manuscript and relatively new manuscript 
for at least the last ten years. The 
inaccessible manuscript, a relatively old 
manuscript is the used exclusion criteria in 
this literature review manuscript. 
 
 
As mentioned earlier, RS3PE tends to 
occur in the elderly population and male 
gender even if there is recent literature 
mentioned there is an unusual case of 
RS3PE occurred in a relatively young 
person.[2,20] There is a strong correlation 
between RS3PE and other rheumatic 
conditions especially EORA (Elderly-
Onset Rheumatoid Arthritis) and PMR as 
its most affected population is the elder. 
Pitting edema at the upper or lower (less 
common) extremity, mild symmetrical 
synovitis, and negativity to RF tests are the 
most clinically significant features to 
differentiate these closely related 
pathologies.[7] Radiographic investigation 
of RS3PE affected person also shows no 
juxta-articular erosion as it’s heavily 
featured in RA. The symmetrical 
involvement characteristic of RS3PE is 
accepted worldwide and considered its 
pathognomonic feature until some reported 
cases mention unilateral involvement of 
RS3PE cases. However, all reported cases 
were associated with neurological deficits 
such as stroke (hemiplegia) or brachial 
plexus palsy and the affected limb is 
contralateral to the side of the affected 
neurological deficit limb.[2,4,21]  
 Therefore, an neurological 
impairment condition of a limb was shown 
to be not affected by RS3PE. This 
condition appears to be closely related to 
RS3PE pathogenesis that somehow 
remains unclear but the hypothesized 
theory shows the role of VEGF (Vascular 
Endothelial Growth Factor) as the most 
commonly accepted theory. VEGF is a 
potent vasodilator and able to increase 
vascular permeability thus explain the 
pitting edema or polysynovitis feature of 
RS3PE. [4,12,20-21]  
Figure 1. Pitting edema of the hands, 
synovitis, and loss of ability to grip which 
marked the diagnosis of RS3PE and descrive 
its sign and symptoms thoroughly.[7]  
RS3PE is not always used as a single 
clinical diagnosis because it is also 
categorized as one of many paraneoplastic 
rheumatic syndromes related to the 
underlying malignancy with multi-system 
involvement.[19] There are so many 
reported cases regarding RS3PE as a 
paraneoplastic syndrome with variated 
malignancy from hematological 
malignancies such as non-Hodgkin’s 
lymphoma, leukemia, and myelodysplastic 
syndrome to solid tumor including 
adenocarcinoma of the ovaries, and other 
associated malignancies from the 
gastrointestinal tract, lung, urinary tract, 
etc.[7]  
Sakamoto et al. in 2017 reported a 
case of a person suffered from lung 
adenocarcinoma with RS3PE as its 
paraneoplastic syndrome that subsides 
rapidly after gefitinib therapy started by 28 
days and achieve complete remission for 
either its underlying malignancy and 
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Sarkar et al. in 2018 stated a case of 
RS3PE with gastric carcinoma proofed by 
post-mortem gastric-biopsy. The patient 
stated the symptoms of its RS3PE had 
started for one month before the hospital 
admission as a painful hand with 
fluctuating in severity accompanied by 
constant increasing swelling of the dorsum 
of both hands. The laboratory test was 
done with a negative outcome for RF and 
an increase in serum ESR level 
(Erythrocyte Sedimentation Rate). The end 
of this case is patient passed away after 
having a massive melena two days after.[22] 
 
Figure 2. Edema or sweilling of the dorsum of 
both hand which can be found in a person with 
an active RS3PE syndrome. The person in the 
figure was diagnosed with adenocarcinoma of 
the caecum which exhibited RS3PE as its 
paraneoplastic syndrome.[23] 
Pratas et al. published a case report 
manuscript in 2018 about patients in mid-
2015 with adenocarcinoma of the caecum 
that presents with RS3PE as its 
paraneoplastic syndrome. As in other 
RS3PE cases, the patient was having 
bilateral or symmetrical polyarthralgia of 
the metacarpophalangeal and proximal 
interphalangeal joints and pitting edema of 
the dorsum of the hand accompanied by 
6/10 pain with exacerbations event with 
movement. The patient was given 
prednisolone for one month before the 
patient underwent an operative procedure 
regarding its condition (hemicolectomy). 
There is neither neoplastic nor RS3PE 
syndrome relapse for three years after.[23] 
Puerto et al. in 2013 reported another 
two cases of RS3PE with one this case 
reported RS3PE as a paraneoplastic 
syndrome from an 81-year-old man 
diagnosed with PCa (Prostate Cancer) 
before hospital admission. The clinical 
feature is no different from reported cases 
stated earlier. Therefore, the patient treated 
with low-dose glucocorticoid (prednisone 
5 mg/day) and the patient achieve its 
clinical improvement until 13 months 
later.[24] 
Another case report literature shows a 
case of angioimmunoblastic T-cell 
lymphoma preceded by RS3PE as its 
paraneoplastic syndrome. Tabeya et al. in 
2013 mentioned the correlation of the 
underlying malignancy of a 76-year-old 
man and its high VEGF serum which the 
literature said was 572 pg/ml and perhaps 
being the main cause of the RS3PE 
syndrome. Tabeya et al. also suspected the 
high VEGF level is originated by 
lymphoma cells as it’s expressing VEGF-
A thus inducing the paraneoplastic 
syndrome. The patient responds well to 
glucocorticoid pulse therapy; although an 
underlying malignancy caused it, the 
patient was also given chemotherapy 
during hospitalization. Respond to certain 
glucocorticoid therapy can identify the 
etiology of RS3PE syndrome at some 
point. RS3PE patients with relative 
resistance to glucocorticoid therapy should 
be suspected for malignancy as its 
etiology.[25] 
A recent case report from Yajima et 
al. in 2020 about manifested RS3PE 
syndrome inpatient with another prostatic 
carcinoma (PCa) showed that 
paraneoplastic syndrome achieves a 
complete remission state after the 
operative procedure or surgical resection is 
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Figure 3. Bone scintigraphy analysis of a person before the development of the RSEP3 (left), at the 
time of RS3PE flare (middle), and 4 months after receiving methotrexate as his therapeutic therapy 
regarding its underlying malignancy of musculoskeletal system which showed a remission of the 
symptoms (right). The high signal from the right hemipelvis, both ischial tuberosities, and several left 
ribs are the result from the underlying malignancy and metastases thus does not correlate directly 
toward the workup of RS3PE activity which staged by the signal from both hands specifically wrist 
and metacarpophalangeal joint.[27] 
 
was diagnosed with PCa two months 
before the RS3PE syndrome appeared. The 
manifested symptoms are arthralgia in 
both shoulders and knees with pitting 
edema of both hands and feet. Similar to 
the case presented by Pratas et al., the 
patient was given low dose prednisolone 
(15 mg/day) which showed improvement 
in the paraneoplastic symptoms. But as 
mentioned earlier, the patient achieves the 
complete remission of either PCa 
symptoms or its paraneoplastic syndrome 
after the surgical procedure.[26] 
The most recent case report was 
published by Kim et al. in May 2020 about 
a 59-years-old man diagnosed with 
metastatic prostate cancer to the 
musculoskeletal system (right pubic ramus 
and left ischiopubic junction in this case 
series). Similarly, with other reported 
cases, the patient presented with abruptly 
onset pain and swelling in his right hand 
which the symptoms appeared to be self-
resolved over a few days. The symptoms 
were suggested to be its paraneoplastic 
syndrome originated from its underlying 
malignancy and also mentioned to 
interfered with his daily life greatly due to 
the inability to make a fist. Antinuclear 
antibody, RF, and anti-CCP were also 
appeared to be negative. At the end of the 
report, the cancer was still progressing 
thus he received radium-223 therapy with 
no further mention of his paraneoplastic 
symptoms.[27] 
Other cases about RS3PE posed as a 
paraneoplastic syndrome of underlying 
malignancies showed an almost similar 
clinical presentation and characteristic to 
achieve complete remission. Silte et al. in 
2014 reported a case of RS3PE with 
another PCa patient[28], Emamifar et al. 
reported another almost similar case in 
2016[29], Sarkar et al. previously also had 
reported a rare association of RS3PE 
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with phyllodes tumour of breast[30], 
another case of RS3PE appeared in female 
population even if its nature to be closely 
related to male population was presented 
by Ohe in 2014 about a case of a patient 
with breast carcinoma which presented 
with an RS3PE syndrome[31], Dhingani et 
al. also reported another case of RS3PE 
syndrome manifested in a patient with 
adenocarcinoma of the lung[32], and the last 
series of a case report that will be 
mentioned in this paper is a reported case 
by Salcido-de Pablo et al. in 2014 about 
another elderly patient with malignancy 
(colon cancer) and RS3PE as its 
paraneoplastic syndrome.[33] 
 
Figure 4. Posterior-anterior (PA) radiographs 
of the hands bilaterally in the flaring stage of 
the RS3PE which showing the abcence of the 
bony erosive change unlike rheumatoid 
arthritis or several seropositive rheumatologic 
condition.[7] 
There are many published works of 
literature worldwide especially in the last 
ten years regarding either stand-alone 
studies or case reports of RS3PE and its 
correlation with other pathologies 
including malignancies. The conclusion of 
the 12 case reports previously mentioned 
is the patient with RS3PE as its 
paraneoplastic syndrome resulting from 
underlying malignancy appears to be 
closely related to its etiology. Whether its 
symptoms or remission. Thus, the best 
treatment for paraneoplastic symptoms is 
the etiologic treatment focused on 
underlying malignancy such as surgical 
resection or chemotherapy.[2,22-33] 
As mentioned earlier, the pathology of 
RS3PE is closely related to VEGF either 
its idiopathic form or paraneoplastic form. 
VEGF acts as a potent angiogenic and 
vasogenic molecule thus able facilitating 
hypervascularity and increasing vascular 
permeability so caused synovitis and sub-
cutaneous edema respectively.[34-35] 
In terms of malignancies, VEGF acts 
as a key role in its pathology as an 
important growth factor because of VEGF 
nature as a potent angiogenic molecule. 
High level or over-expression of VEGF 
can also be found in other rheumatological 
pathologies such as rheumatoid arthritis or 
psoriasis. Induction of vascularization for 
the cancer cells is provided by VEGF at a 
high level thus forming a neo-
vascularization to supply the cancer cells. 
Because every tissue in the body certainly 
needs vascularization as a provider of the 
nutrient flow, VEGF is known to be 
expressed in most tumor cases, especially 
malignancies in every multi-system 
possible and certainly highly correlates 
with its progression. VEGF expression 
also has a higher association with digestive 
system cancer such as gastric cancer, 
colorectal cancer, pancreatic cancer, etc. 
Although the level of VEGF in other 
malignancies includes prostate and breast 
cancer should never be neglected.[36-39] 
High level of VEGF condition in person 
with malignancy caused the possibility of 
its con dition to induce some 
paraneoplastic syndrome including or 
especially RS3PE.[10,12,18-19,27] 
Besides RS3PE pathology, several 
genetic factors are known to be closely 
related to the emergence of the syndrome 
in some persons thus explaining not every 
person with certain malignancy especially 
some pathology with high VEGF level will 
develop RS3PE at its progression. HLA-
B7, HLA-A2, and HLA-Cw7. These 
specific genes also explain the reason 
behind more significantly and certain 
relative tendencies regarding its 
musculoskeletal involvement in some 
paraneoplastic syndromes especially 
RS3PE which presumed correlated with 
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genes and several rheumatologic 
conditions. Nevertheless, Paik et al. in 
2019 mentioned the existence of a specific 
HLA gene namely HLA-DRB1 does not 
correlate with the occurrence of RS3PE in 
a person as its absence is one of the 
features of the genetic workup in an 
RS3PE patient. Eventually, the occurrence 
of RS3PE in a person is resulted from 
several and certain factors whether internal 
or external or even resulted from an 
underlying malignancy which also 




RS3PE has been strongly correlated 
with several malignancies mostly prostate 
cancer and colorectal cancer with a fewer 
number of reported as its etiologies even 
the primary or “pure” form of RS3PE 
exists. VEGF is known as a causal 
substance for RS3PE syndrome, which is 
proven by some studies the high level of 
VEGF is found either in primary RS3PE 
patient or patient with malignancy, which 




Further development and study 
regarding the correlation or association of 
several malignancies with the occurrence 
of RS3PE as its paraneoplastic syndrome 
should be done in the future thus justify 
the clinician awareness. The understanding 
and comprehension of the nature of 
RS3PE as a paraneoplastic syndrome 
should lead to the advanced workup which 
able to detect, thus preventing the 
progression of underlying neoplastic even 
if the primary or “pure” form of RS3PE 
remain.  
The necessity toward a broad-type 
systematic review and meta-analysis 
publication remain high as the most 
published literature focused on RS3PE are 
dominated by case study publications thus 
only recap the condition of one or several 
patients which unable to explore several 
potential factors on a larger scale, e.g., 
assuring its correlation with a more 
specific neoplastic rather than only a 
suggestion of the VEGF’s role which 
upregulated in several malignancies, or 
elaborate the correlation between a 
specific risk factor of a specific 
malignancy which certainly exhibited a 
different factor one to each other thus 
obscured another risk factor for the 
development of RS3PE, or even 
explaining the exact and comprehensive 
pathology which remain unclear until now. 
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